vimarsana.com

Latest Breaking News On - Malignant hematology - Page 10 : vimarsana.com

Educated Patient® Multiple Myeloma Summit BiTE and Future Myeloma Directions Presentation: April 8, 2023

Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

United statesKennethh shainMoffitt cancer centerDepartment of malignant hematologyMalignant hematologyTumor biologyEducated patientMultiple myeloma

New FDA Guidance Clinical Trial Considerations To Support Accelerated Approval Of Oncology Therapeutics

On April 6, 2023, AbbVie announced that it was voluntarily withdrawing ibrutinib, which was granted accelerated approval for two indications: mantle.

Marjoriee zettlerDrug administrationOncologic drugs advisory committeeRegor pharmaceuticals incDrug administration expedited developmentUs government accountability officeOncology centerDrug administration accelerated approval of malignant hematologyRegor pharmaceuticalsProject confirmReduce riskRequire stronger evidence of safety andDrug omnibus reform actConsolidated appropriations actMantle cell lymphomaMarginal zone lymphoma

Educated Patient® Multiple Myeloma Summit Myeloma Management Panel: April 8, 2023

Watch Dr. Brandon J Blue, Dr. Dickran Kazandjian and Dr. Marc J. Braunstein answer questions about disease management during the CURE Educated Patient Multiple Myeloma Summit.

United statesUniversity of miamiNew yorkMarcj braunsteinDickran kazandjianMyeloma centerMyeloma management panelMoffitt cancer centerLangone healthBrandonj blueMalignant hematologyMiami health systemBrandon blue

Educated Patient® Multiple Myeloma Summit Disease Overview Panel: April 8, 2023

Watch Dr. Ariel Grajales-Cruz and Dr. Brandon J Blue answer questions about myeloma during the CURE Educated Patient Multiple Myeloma Summit.

United statesAriel grajales cruzBrielle benyonInternational myeloma foundationMoffitt cancer centerInternational studies systemLymphoma societyAmerican cancer societyDrug administrationMyeloma research foundationInternational staging systemBrandonj blueMalignant hematologyMoffitt cancerMultiple myeloma research foundation

Educated Patient® Multiple Myeloma Summit Health Disparities Presentation: April 8, 2023

Watch Dr. Brandon Blue, from Moffitt Cancer Center, discuss health disparities during the CURE Educated Patient Multiple Myeloma Summit.

United statesEnd results programVeterans administrationNational cancer institute surveillanceEducated patientMultiple myelomaMalignant hematologyMoffitt cancer centerAfrican americanAfrican americansNational cancer instituteEnd results

vimarsana © 2020. All Rights Reserved.